Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | FNTA | P49354 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 9/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | BCL2 | P10415 | 7/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL28466761 | 0.95 | ALDH1A1 (0.52) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL27015580 | 0.91 | FNTA (0.55) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL9414347 | 0.85 | ALDH1A1 (0.53) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL25922759 | 0.82 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL5316894 | 0.82 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL214415 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL19717960 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL29626008 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL7736938 | 0.81 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AMAPTFNTA | |
| SCHEMBL21609554 | 0.80 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2AMAPTFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016196696-A1 | COMPACTED LIQUID LAUNDRY DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-08 | — | — | WO | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| US-6780835-B2 | DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX | QUEST INTERNATIONAL B.V. (NL) | 2004-08-24 | — | — | US | claimed |
| US-11958030-B2 | Coacervate core-shell microcapsules | FIRMENICH SA (CH) | 2024-04-16 | — | — | US | disclosed |
| US-20240018101-A1 | MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY | UNIVERSITY OF SAN DIEGO | 2024-01-18 | — | — | US | disclosed |
| US-20230149878-A1 | COACERVATE CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | disclosed |
| US-11352314-B2 | Fruity odorant | FIRMENICH SA (CH) | 2022-06-07 | — | — | US | disclosed |
| WO-2021185724-A1 | MICROCAPSULES COATED WITH A POLYSUCCINIMIDE DERIVATIVE | FIRMENICH SA (CH) | 2021-09-23 | — | — | WO | disclosed |
| EP-3774017-A1 | PROCESS FOR PREPARING POLYSUCCINIMIDE DERIVATIVES-BASED MICROCAPSULES | Firmenich SA (CH) | 2021-02-17 | — | — | EP | disclosed |
| EP-3746216-A1 | PROCESS FOR PREPARING MICROCAPSULES | Firmenich SA (CH) | 2020-12-09 | — | — | EP | disclosed |
| EP-3746218-A1 | PROCESS FOR PREPARING MINERALIZED MICROCAPSULES | Firmenich SA (CH) | 2020-12-09 | — | — | EP | disclosed |
| WO-2009128026-A1 | KETONES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2009-10-22 | — | — | WO | disclosed |
| US-20080260670-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2008-10-23 | — | — | US | disclosed |
| EP-1487815-A1 | COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE ALDEHYDES | FIRMENICH SA (CH) | 2004-12-22 | — | — | EP | disclosed |
| US-6780835-B2 | DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX | QUEST INTERNATIONAL B.V. (NL) | 2004-08-24 | — | — | US | disclosed |
| US-6713410-B1 | DEPOSITING A PERFUME MIXTURE WHICH PREFERENTIALLY DEPOSIT ON SPANDEX FIBERS AND IS RETAINED BETTER THAN ON OTHER TEXTILE FIBERS; WASHING; DEODORANT | E.I. DU PONT DE NEMOURS AND CO. | 2004-03-30 | — | — | US | disclosed |
| WO-2003082850-A1 | COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE ALDEHYDES | FIRMENICH SA (CH) | 2003-10-09 | — | — | WO | disclosed |
| US-6465420-B1 | YARN OR FABRIC COMPRISING COTTON AND SPANDEX FIBRES, HAVING A PERFUME COMPOSITION DEPOSITED ON THE SAID YARN OR FABRIC | QUEST INTERNATIONAL B.V. (NL) | 2002-10-15 | — | — | US | disclosed |
| EP-1023480-A1 | METHOD FOR TEXTILE TREATMENT FOR SPANDEX CONTAINING FABRICS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999019553-A1 | METHOD FOR TEXTILE TREATMENT FOR SPANDEX CONTAINING FABRICS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018101-A1 | MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY | BOLA2; BOLA2B, GHITM, GGPS1 | ALDH1A1 2321/4885MEN1 2536/4885KMT2A 2967/4885 |
| US-20080260670-A1 | Organic Compounds | OR10J3, OR51E2, ELOVL1 | ALDH1A1 39/4885MEN1 2199/4885KMT2A 682/4885 |
| US-11352314-B2 | Fruity odorant | C5, TAS1R3, TAS1R1 | ALDH1A1 142/4885MEN1 2114/4885KMT2A 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.